Literature DB >> 30827250

Giant Cell Arteritis (GCA): Pathogenesis, Clinical Aspects and Treatment Approaches.

Andrea Ciofalo1, Giampiero Gulotta1, Giannicola Iannella1, Benedetta Pasquariello1, Alessandra Manno1, Diletta Angeletti1, Annalisa Pace1, Antonio Greco1, Giancarlo Altissimi1, Marco de Vincentiis1, Giuseppe Magliulo1.   

Abstract

Giant Cell Arteritis (GCA), or Horton's Arteritis, is a chronic form of vasculitis of the large and medium vessels, especially involving the extracranial branches of the carotid arteries, in particular, the temporal artery, with the involvement of the axillary, femoral and iliac arteries too. Arterial wall inflammation leads to luminal occlusion and tissue ischemia, which is responsible for the clinical manifestations of the disease. A substantial number of patients affected by GCA present head and neck symptoms, including ocular, neurological and otorhinolaryngological manifestations. The aim of this article is to present pathogenesis, clinical aspects and treatment approaches of GCA manifestations. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Autoimmune disease; ENT; GCA; audiovestibular abnormalities; hearing loss; polymyalgia rheumatica; vasculitis.

Mesh:

Substances:

Year:  2019        PMID: 30827250     DOI: 10.2174/1573397115666190227194014

Source DB:  PubMed          Journal:  Curr Rheumatol Rev        ISSN: 1573-3971


  2 in total

Review 1.  Autoimmune disease of head and neck, imaging, and clinical review.

Authors:  Alireza Paydar; Zachary B Jenner; Tyrell J Simkins; Yu-Ming Chang; Lotfi Hacein-Bey; Arzu Ozturk; Andrew Birkeland; Reza Assadsangabi; Osama Raslan; Ghazal Shadmani; Michelle Apperson; Vladimir Ivanovic
Journal:  Neuroradiol J       Date:  2022-05-22

2.  Pericardial effusion in giant cell arteritis is associated with increased inflammatory markers: a retrospective cohort study.

Authors:  Quentin Gomes de Pinho; Aurélie Daumas; Audrey Benyamine; Julien Bertolino; Pascal Rossi; Nicolas Schleinitz; Jean-Robert Harlé; Pierre André Jarrot; Gilles Kaplanski; Julie Berbis; Brigitte Granel
Journal:  Rheumatol Int       Date:  2022-05-07       Impact factor: 3.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.